Results 171 to 180 of about 373,614 (309)

Divergent roles of angiotensin II upon the immediate and sustained increases of renal blood flow following unilateral nephrectomy.

Am J Physiol Renal Physiol, 2022
Shimada S, Yang C, Kurth T, Cowley AW.
europepmc   +1 more source

Changes in hemodynamics, renal blood flow and urine output during continuous renal replacement therapies. [PDF]

Sci Rep, 2020
Fernández SN, Santiago MJ, González R, López J, Solana MJ, Urbano J, López-Herce J.   +6 more
europepmc   +1 more source

THE RENAL BLOOD FLOW IN COARCTATION OF THE AORTA [PDF]

Journal of Clinical Investigation, 1941
M, Friedman, A, Selzer, H, Rosenblum, P, McLean, W, Picard   +4 more
openaire   +2 more sources

The Development and Pilot Clinical Study of CD147 Targeted Antagonistic Peptide Probe for Tumor Imaging

Advanced Science, EarlyView.
This study establishes [68Ga]Ga‐DOTA‐AP9 as a first‐in‐human CD147‐targeted PET tracer with favorable safety and specific tumor uptake. Tracer accumulation correlates with CD147 expression in patients, enabling noninvasive quantification of CD147‐positive malignancies.
Xiaokun Ma, Rui Guo, Dongfeng Niu, Yufei Song, Zhenyao Zhang, Xiangxi Meng, Lili Mao, Haifeng Huang, Hua Zhu, Zhi Yang, Teli Liu   +10 more
wiley   +1 more source

Cardiorenal Hemodynamic Coupling: Mechanical Circulatory Support Augments Renal Blood Flow via Renal Vasodilation. [PDF]

JACC Basic Transl Sci
Zale RE, Edelman ER.
europepmc   +1 more source

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

Advanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang, Kejia Li, Ning Wang, Zhen Li, Zhiyong Zhang, Rocky S. Tuan, Yangzi Jiang   +6 more
wiley   +1 more source

Rethinking flow: the paradox of renoprotection without increased renal blood flow in cardiopulmonary bypass. [PDF]

J Thorac Dis
Mohan S, Shaju RA, Misra S, Sharma T, Sirivolu VK, Rajkumar A, Rodas-Camacho A, Zaidi A, Dhingra D, Khan I, Bhattacharya R, Pancholy V, Banerjee S, Ghosh S, Li S, Liao KK, Walther CP, Mondal NK.   +17 more
europepmc   +1 more source

Results of Surgical Repair of Hilar Renal Artery Aneurysm to Preserve Renal Blood Flow. [PDF]

Ann Vasc Dis, 2020
Kawase T, Inoue Y, Matsuo J, Omura A, Seike Y, Uehara K, Sasaki H, Matsuda H.   +7 more
europepmc   +1 more source

S100A14 in Tumor‐Derived EVs Targets PIAS3 to Reprogram Astrocytes and Induce Immunosuppressive Microenvironment Promoting Brain Metastasis and Germacrone Reversal Effect

Advanced Science, EarlyView.
This study identifies S100A14 in tumor‐derived exosomes as a key driver of brain metastasis. S100A14 targets PIAS3 in astrocytes, activating STAT3 signaling and promoting immunosuppressive MDSCs recruitment via chemokine secretion. Germacrone, a natural compound, binds S100A14 to disrupt this axis, effectively inhibiting brain metastasis with low ...
Qian Feng, Xia Yang, Lin An, Xue‐Yu Wang, Ming‐Rui Wang, Zhuo‐Hong Cai, Cai‐Jun Xie, Li‐Jun Qiao, You‐Bi Shen, Xi‐Min Liang, Rong Zhang, Cai‐Yan Wang, Zhong‐Qiu Liu, Rong‐Rong Zhang   +13 more
wiley   +1 more source

A PUMA-G receptor élettani és kórélettani szerepe az agyi vérkeringésben. = Role of the PUMA-G receptor in the cerebral circulation.

, 2010
Eredményeink szerint a PUMA-G receptor nem játszik szignifikáns szerepet az agykérgi véráramlás szabályozásában sem élettani sem pedig kórélettani körülmények között.
Lenzsér, Gábor, Horváth, Béla András, Sándor, Péter, Örsy, Petra, Hermán, Péter, Benyó, Zoltán   +5 more
core